ArticleJournal of cancer survivorship : research and practice2025
Return to work after neoadjuvant versus adjuvant immunotherapy in stage III melanoma patients.
J M Lijnsvelt et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it